JP2023512824A5 - - Google Patents

Info

Publication number
JP2023512824A5
JP2023512824A5 JP2022548118A JP2022548118A JP2023512824A5 JP 2023512824 A5 JP2023512824 A5 JP 2023512824A5 JP 2022548118 A JP2022548118 A JP 2022548118A JP 2022548118 A JP2022548118 A JP 2022548118A JP 2023512824 A5 JP2023512824 A5 JP 2023512824A5
Authority
JP
Japan
Prior art keywords
sequence
seq
protein
acid sequence
promoter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022548118A
Other languages
English (en)
Japanese (ja)
Other versions
JP7846626B2 (ja
JP2023512824A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/016720 external-priority patent/WO2021158854A2/en
Publication of JP2023512824A publication Critical patent/JP2023512824A/ja
Publication of JP2023512824A5 publication Critical patent/JP2023512824A5/ja
Application granted granted Critical
Publication of JP7846626B2 publication Critical patent/JP7846626B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022548118A 2020-02-07 2021-02-05 大型遺伝子ベクターならびにその送達および使用の方法 Active JP7846626B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062971555P 2020-02-07 2020-02-07
US62/971,555 2020-02-07
PCT/US2021/016720 WO2021158854A2 (en) 2020-02-07 2021-02-05 Large gene vectors and delivery and uses thereof

Publications (3)

Publication Number Publication Date
JP2023512824A JP2023512824A (ja) 2023-03-29
JP2023512824A5 true JP2023512824A5 (cg-RX-API-DMAC7.html) 2024-02-14
JP7846626B2 JP7846626B2 (ja) 2026-04-15

Family

ID=77200426

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022548118A Active JP7846626B2 (ja) 2020-02-07 2021-02-05 大型遺伝子ベクターならびにその送達および使用の方法

Country Status (8)

Country Link
US (1) US20230090778A1 (cg-RX-API-DMAC7.html)
EP (1) EP4100518A4 (cg-RX-API-DMAC7.html)
JP (1) JP7846626B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220139924A (cg-RX-API-DMAC7.html)
AU (1) AU2021216410A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022015601A2 (cg-RX-API-DMAC7.html)
CA (1) CA3170709A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021158854A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL325122A (en) 2018-02-22 2026-02-01 Akouos Inc Compositions and methods for treating non-age-related hearing impairment in humans
JP2021530227A (ja) 2018-07-13 2021-11-11 アコーオス インコーポレイテッド 非症候性感音性聴力喪失の治療方法
US12667628B2 (en) 2019-07-03 2026-06-30 Children's Medical Center Corporation Compositions and methods for gene replacement
CA3168055A1 (en) 2020-02-21 2021-08-26 Emmanuel John Simons Compositions and methods for treating non-age-associated hearing impairment in a human subject
US20240352086A1 (en) * 2021-08-24 2024-10-24 The Regents Of The University Of California Compositions and methods comprising lipid associated transmembrane domains
CN116836975A (zh) * 2022-03-25 2023-10-03 上海玮美基因科技有限责任公司 一种耳蜗和/或前庭细胞特异性启动子及其应用
CN117106824B (zh) * 2022-05-17 2025-09-02 上海佑音医药生物科技有限公司 一种治疗听力损伤的双载体系统及其应用
EP4724470A1 (en) 2023-06-12 2026-04-15 Children's Hospital Medical Center Aav-cftr vectors and methods of using same
CN116925239B (zh) * 2023-07-17 2024-10-18 苏州星奥拓维生物技术有限公司 双载体系统表达Otof基因的组合物和方法
CN118308390A (zh) * 2024-04-24 2024-07-09 广州派真生物技术有限公司 一种内含肽联用载体及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002046208A2 (en) * 2000-11-01 2002-06-13 Elusys Therapeutics, Inc. Method of producing biospecific molecules by protein trans-splicing
CN101595228A (zh) * 2005-07-21 2009-12-02 艾博特公司 包括sorf构建体的多基因表达和使用多蛋白、前体蛋白和蛋白酶解的方法
JP2013509188A (ja) * 2009-10-30 2013-03-14 アボット・ラボラトリーズ Sorf構築物および複数の遺伝子発現
JP6177780B2 (ja) * 2011-09-28 2017-08-09 エラ、ビオテック、ソシエダッド、アノニマEra Biotech, S.A. スプリットインテインおよびその使用
CA2979120A1 (en) 2015-03-03 2016-09-09 Fondazione Telethon Multiple aav vector system for expressing genes over 5 kilobases, comprising at least one degradation signal and uses thereof
WO2017209280A1 (ja) * 2016-06-03 2017-12-07 国立大学法人鹿児島大学 酵母と断片化cDNAライブラリーを用いたタンパク質の新しい同定法
KR20240007715A (ko) * 2016-10-14 2024-01-16 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵염기 에디터의 aav 전달
MA47820A (fr) * 2017-03-10 2020-01-15 Genethon Traitement de la glycogénose de type iii
WO2018226602A1 (en) * 2017-06-05 2018-12-13 Research Institute At Nationwide Children's Hospital Enhanced modified viral capsid proteins
JP2021530227A (ja) * 2018-07-13 2021-11-11 アコーオス インコーポレイテッド 非症候性感音性聴力喪失の治療方法
CA3116606A1 (en) 2018-10-15 2020-04-23 Fondazione Telethon Intein proteins and uses thereof

Similar Documents

Publication Publication Date Title
JP2022554300A5 (cg-RX-API-DMAC7.html)
JP2023518596A5 (cg-RX-API-DMAC7.html)
CN101287748B (zh) 一种融合蛋白的组成及其分离方法
JP2025166834A5 (cg-RX-API-DMAC7.html)
Gershon et al. Early transcription factor subunits are encoded by vaccinia virus late genes.
JP2018537087A5 (cg-RX-API-DMAC7.html)
Weber Amino acid sequence studies on the tryptic peptides of the coat protein of the bacteriophage R17
JP2019506166A5 (cg-RX-API-DMAC7.html)
JP2022513308A5 (cg-RX-API-DMAC7.html)
JP2022522650A5 (cg-RX-API-DMAC7.html)
JP2018171063A5 (cg-RX-API-DMAC7.html)
CA2299677A1 (en) Preparation and use of recombinant influenza a virus m2 constructs and vaccines
JP2023514611A5 (cg-RX-API-DMAC7.html)
JP2023500957A5 (cg-RX-API-DMAC7.html)
FI4034555T3 (fi) Dap10/dap12-fuusiopolypeptidit
JP2025510781A5 (cg-RX-API-DMAC7.html)
Chen et al. Competition between functional signal peptides demonstrates variation in affinity for the secretion pathway
JP2024503091A5 (cg-RX-API-DMAC7.html)
JP3781771B2 (ja) 新規ポリペプチド及びそれをコードするdna
JPWO2020027010A5 (cg-RX-API-DMAC7.html)
JP2002517193A5 (cg-RX-API-DMAC7.html)
US10294284B2 (en) Method for preparing C1q recombinant protein
EP4471138A1 (en) Iga protease truncation, fusion protein comprising iga protease truncation, and use thereof
JP2023524981A5 (cg-RX-API-DMAC7.html)
JP2022545625A5 (cg-RX-API-DMAC7.html)